Tag: ASEAN

TEWKSBURY, MA / ACCESSWIRE / April 25, 2024 / Cambridge Isotope Laboratories, Inc. (CIL) has acquired an additional 14.8 acres of land at its Cambridge Isotope Separations (CIS) Xenia, Ohio location. Mike Steiger, Vice President of Engineering and Project Execution for CIL, stated that the new land purchase will ensure easier access to utilities for future expansion.

This newly acquired land is situated to the west of the 20 acres purchased in 2017, which is currently the site of the North Star expansion project. This recently completed project will greatly increase ¹³C production and is in the startup phase. North Star is the largest ¹³C separation facility ever built in the world and will significantly increase CIL’s capacity ensuring customer reliability for this stable isotope.

The land acquired provides the business flexibility to expand in the future as the demand continues to grow worldwide in all applications. "This investment shows CIL’s commitment to innovation and growth for our customers," said CEO Cliff Caldwell. "CIL works closely with our diverse and global customers to develop and commercialize exciting, high-value applications for isotopically labeled compounds. As these applications commercialize, our customers rely on CIL’s ability to scale our chemistry quickly and reliably. This land acquisition assures we have the space to continue meeting their expectations and enable these technology advancements."

The CIS facility has the world’s largest ¹³C separation facility, is one of the world’s largest ¹⁸O isotope-separation facilities and houses the largest commercial D₂O re-enrichment columns in the world.

Stable isotopes, particularly deuterium, have seen an increase in commercial-scale applications in the last few decades. These applications include pharmaceuticals, semiconductors, flat panel displays, and other high-technology fields. CIL has a three-year supply contract with one Canadian source for D₂O, as well as three other sources, and holds an average of an 18-24-month supply in four of CIL locations to ensure the most reliable supply.

About Cambridge Isotope Laboratories, Inc.    

CIL is the world’s largest manufacturer and global supplier of stable isotopes and stable isotope-labeled compounds used in research, environmental, neonatal, pharmaceutical, medical diagnostic, OLED, and industrial markets. CIL subsidiary ABX in Dresden, Germany, is active in the development and commercialization of radio isotopic-labeled compounds for the diagnosis and treatment of cancers. CIL is an operating business owned by Otsuka Pharmaceutical. The CIL business consists of two facilities in the Boston, Massachusetts, area; a large isotope-enrichment production plant in Xenia, Ohio; CIL China; CIL Canada; ABX in Dresden, Germany; and Eurisotop in Saclay, France. For more information on CIL, visit isotope.com.

Contact Information

Crissy Krisko
crissyk@isotope.com
1.978.269.1930

SOURCE: Cambridge Isotope Laboratories, Inc.

View the original press release on newswire.com.

SAN DIEGO, CA / ACCESSWIRE / April 24, 2024 / General Atomics Aeronautical Systems, Inc. (GA-ASI) has been selected to build production representative flight test articles of the Collaborative Combat Aircraft (CCA) for the U.S. Air Force Life Cycle Management Center’s (AFLCMC) Advanced Aircraft Division. This option contract award by the Advanced Aircraft Division exercises the critical design, build, and flight test on the existing CCA contract with GA-ASI following an initial six-month phase that culminated in a successful CCA preliminary design review (PDR) earlier this year.

The CCA program aims to be a force multiplier, developing a low-cost, modular, unmanned aircraft equipped with advanced sensors or weapons and operating in collaborative teams with the next generation of manned combat aircraft.

In February 2024, GA-ASI successfully conducted the maiden flight of the XQ-67A CCA prototype aircraft validating the "genus/species" concept pioneered by the Air Force Research Laboratory (AFRL) as part of the Low-Cost Attritable Aircraft Platform Sharing (LCAAPS) program. This program focused on building several aircraft variants from a common core chassis. Since then, this prototype for CCA has successfully completed two additional test flights, laying the groundwork for a successful production and flight test program. GA-ASI’s CCA production representative design is based upon the XQ-67A Off-Board Sensing Station developed by GA-ASI for the AFRL.

"The CCA program redefines the future of aviation and will shape the USAF acquisition model to deliver affordable combat mass to the warfighter at the speed of relevancy," said Mike Atwood, Vice President of Advanced Programs for GA-ASI.

"Throughout our 30-year history, GA-ASI has been at the forefront of rapidly advancing unmanned aircraft systems that support our warfighters," said GA-ASI President David R. Alexander. "The USAF is moving forward with GA-ASI due to our focused commitment to unmanned air-to-air combat operations and unmatched UAS experience, ensuring the production of the CCA aircraft at scale to deliver affordable combat mass for the warfighter."

To complement the CCA contract, GA-ASI will continue to conduct a series of autonomy and mission system tests on the MQ-20 Avenger^® UAS and XQ-67A to accelerate the readiness of operational autonomy. These live flight tests will continue to demonstrate the readiness of the full mission capability to support the emerging U.S. Air Force Autonomous Collaborative Platforms (ACP).

About GA-ASI

General Atomics Aeronautical Systems, Inc. (GA-ASI), an affiliate of General Atomics, is a leading designer and manufacturer of proven, reliable RPA systems, radars, and electro-optic and related mission systems, including the Predator^® RPA series and the Lynx^® Multi-mode Radar. With more than eight million flight hours, GA-ASI provides long-endurance, mission-capable aircraft with integrated sensor and data link systems required to deliver persistent situational awareness. The company also produces a variety of sensor control/image analysis software, offers pilot training and support services, and develops meta-material antennas.

For more information, visit www.ga-asi.com.

Avenger, Lynx, Predator, SeaGuardian, and SkyGuardian are registered trademarks of General Atomics Aeronautical Systems, Inc.

Contact Information:

GA-ASI Media Relations
asi-mediarelations@ga-asi.com
+1 (858) 524-8101

SOURCE: General Atomics Aeronautical Systems, Inc.

View the original press release on newswire.com.

NEW YORK, NY / ACCESSWIRE / April 24, 2024 / In a digital-first world, content is a strategic asset. Yet organizations seeking to maximize returns on their content are facing greater demands on their content operations than ever before, such as demands for more relevant content, delivered in near real time through a range of channels and across many devices. That’s why Kontent.ai has introduced Mission Control, the Content Management (CMS) industry’s first data-rich content operations dashboard that gives enterprise content teams complete visibility over their content and team workflows. Backed by a bold new brand, unveiled today, Kontent.ai is leading a new era of content management, driving meaningful outcomes for organizations worldwide.

Kontent.ai delivers a powerful blend of insights and AI acceleration
Today’s content teams are expected to deliver relevant content, seamless experiences, and tangible results. This undertaking alone is challenging. Factor in the need to act quickly, while meeting strict regulatory requirements and protecting brand integrity-and that challenge becomes immense. For large organizations especially, moving content from planning to publishing can contain frustrating bottlenecks and inefficiencies. But you can’t fix what you can’t see. And you can’t optimize what you can’t measure.

Kontent.ai’s Mission Control, a first in the CMS world, is solving this black box of content operations. With actionable insights into workflow efficiency, team performance, author workload, and more, content teams can take targeted action to improve their processes and results. Mission Control is a critical complement to Kontent.ai’s AI capabilities, another industry milestone. Leveraging AI to accelerate authoring, localization, translation, legal review, and ongoing maintenance and governance of content can deliver a radical step-change for organizations.

"Over the past six months, our teams have been developing a powerful suite of enterprise-grade capabilities, including Mission Control, designed to deliver transformational outcomes to our clients across their entire content operations," said Mark Ruddock, CEO of Kontent.ai.

As Kontent.ai solves both long-standing and emerging gaps in content management-through central access to data insights and AI accelerators across the content value chain, matched by tight governance-Kontent.ai customers are already seeing tangible advantages, like:

• Streamlined processes, with an 80% decrease in content administration costs
• Exceptional digital experiences, leading to a 286% increase in customer engagement
• A measurable return on their investment, of 320% or more

As Kieran McGuire, Platform Product Manager from British Red Cross, said, "Everything about Kontent.ai has contributed to remarkable time savings for us. Their clear and user-friendly interface makes creating and publishing content easy, whilst their straightforward API and responsive support has made life easier for our developers. We have a great relationship and can trust that our feedback is heard and changing needs are adapted to. Overall, we’re thrilled!"

Kontent.ai’s new brand is a bold signal of what’s to come
Today also marks the unveiling of Kontent.ai’s new brand identity and website, both clear expressions of how the software vendor sees the future of modern content management.

Refreshingly plain-spoken. A focus on real customer stories with quantifiable outcomes. Self-paced discovery of industry solutions, use cases, and product capabilities: Kontent.ai’s website caters to audiences who want to deeply explore the power and possibility of the leading CMS, without having to talk to a salesperson from the get-go.

"At Kontent.ai, our mission is to think differently-leveraging emerging technologies such as generative AI-to help our customers deliver a truly unparalleled return on their content," said Mark Ruddock. "Our new brand and website reflect this. We don’t want to look or sound like what you might expect from traditional players in our sector."

Discover what an unparalleled return on content means for leading organizations like University of Amsterdam, Gordon Ramsay Restaurants, and UNICEF on Kontent.ai’s new website at: kontent.ai.

About Kontent.ai
Kontent.ai’s mission is to help the world’s leading organizations achieve an unparalleled return on their content. In the industry’s first AI-powered CMS, content teams plan, create, and optimize content and deliver it to any channel-quickly, securely, and flexibly. Kontent.ai is designed to support organizations with exacting governance requirements, often in highly regulated industries and with complex content value chains. Tight permissions control all operations; enterprise-grade security and privacy keep content safe. With a demonstrated ROI of 320%, Kontent.ai customers, including PPG, Elanco, Zurich Insurance, Cadbury, and Oxford University, benefit from a measurable step change in how their teams operate, increasing content velocity, mitigating risk, and maximizing yield. Kontent.ai is a Microsoft partner, MACH Alliance member, and recognized vendor by Gartner and Forrester. Learn more at: kontent.ai.

Contact Information
Vojtech Boril
Vice President, Global Marketing
vojtech.boril@kontent.ai
+420776874572

SOURCE: Kontent.ai

View the original press release on newswire.com.

WINCHESTER, UK / ACCESSWIRE / April 23, 2024 / The longest, most comprehensive peer-reviewed study so far has demonstrated that dogs fed nutritionally-sound vegan diets maintain health outcomes as well as dogs fed meat. The study, published in leading scientific journal PLOS ONE, comprehensively assessed the health of 15 dogs by analysing blood cells and biochemistry, blood nutrient levels, urine, veterinary clinical parameters, and monthly pet owner questionnaires. The dogs were fed solely vegan diets based on pea protein for an entire year – just under one tenth of an average dog lifespan, or around seven human years.

Overweight or obese dogs lost weight, whilst the remainder maintained normal weight. No clinically significant changes occurred within blood and urine. Blood levels of amino acids and vitamins were all generally maintained.

In a few cases, previous deficiencies following a meat-based diet either improved or disappeared, including L-taurine and L-carnitine (important for cardiac health), vitamin D (indispensable for immunity and bone health), and folate (required to produce red blood cells).

The study was particularly interesting, given recent suggestions that peas might contribute to heart disease in dogs in the US. Although no credible evidence has been found, such concerns have persisted in some quarters. In the current study, dogs were fed pea-based vegan pet food, for one year. Blood markers of cardiac health were assessed, with no signs of heart disease found. Indeed, in some cases indicators of cardiac health improved.

Stated lead researcher, veterinarian Dr. Annika Linde from the Western University of Health Sciences near Los Angeles says, "Evolutionary adaptations have resulted in a digestive system that enables dogs to maintain health on nutritionally complete omnivorous diets, including those free of animal ingredients. Our study offers new evidence on outcomes in clinically healthy dogs who thrive without consumption of animal-derived ingredients. Notably, foods produced independent of factory farming are also more sustainable and ethical."

Study co-author Dr. Melgarejo highlighted the potential environmental benefits of such diets, "If dogs and cats in the U.S. were their own nation, they would rank fifth in global meat consumption, surpassed only by Russia, Brazil, USA, and China, according to the UCLA Institute of the Environment and Sustainability."

Veterinary Professor Andrew Knight has published several of the key studies in this field, including very large-scale studies showing that both dogs and cats normally achieve equivalent or superior health outcomes, when fed nutritionally-sound vegan diets. He also analysed the environmental benefits of vegan pet diets in a major recent study. He stated that "If all the world’s dogs went vegan, it would save more greenhouse gases than those emitted by the UK, land larger than Mexico, and 450 million additional people could be fed with food energy savings – more than the entire EU population. With 13 studies now demonstrating good health outcomes achieved by nutritionally-sound vegan pet diets, and several others demonstrating major environmental benefits, a compelling case now exists for environmentally-friendly vegan pet diets."

Contact Information:

Andrew Knight
Veterinary Professor of Animal Welfare
andrew.knight@winchester.ac.uk

SOURCE: Representing Animals Foundation

View the original press release on newswire.com.